News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
851,177 Results
Type
Article (86742)
Company Profile (703)
Press Release (763730)
Multimedia
Podcasts (139)
Webinars (18)
Section
Business (232776)
Career Advice (4130)
Deals (39749)
Drug Delivery (129)
Drug Development (91062)
Employer Resources (198)
FDA (18159)
Job Trends (17354)
News (396712)
Policy (39798)
Tag
Academia (3002)
Academic (2)
Accelerated approval (9)
Adcomms (32)
Allergies (103)
Alliances (56937)
ALS (112)
Alzheimer's disease (1536)
Antibody-drug conjugate (ADC) (186)
Approvals (18108)
Artificial intelligence (376)
Autoimmune disease (34)
Automation (18)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (124)
Biotechnology (481)
Bladder cancer (95)
Brain cancer (37)
Breast cancer (377)
Cancer (2922)
Cardiovascular disease (235)
Career advice (3537)
Career pathing (34)
CAR-T (200)
CDC (36)
Cell therapy (550)
Cervical cancer (24)
Clinical research (74032)
Collaboration (1046)
Company closure (3)
Compensation (654)
Complete response letters (30)
COVID-19 (2894)
CRISPR (64)
C-suite (319)
Cystic fibrosis (117)
Data (2878)
Decentralized trials (2)
Denatured (48)
Depression (66)
Diabetes (335)
Diagnostics (6962)
Digital health (24)
Diversity (9)
Diversity, equity & inclusion (49)
Drug discovery (167)
Drug pricing (148)
Drug shortages (35)
Duchenne muscular dystrophy (125)
Earnings (97419)
Editorial (48)
Employer branding (25)
Employer resources (168)
Events (131269)
Executive appointments (890)
FDA (19769)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (960)
Gene editing (142)
Generative AI (37)
Gene therapy (417)
GLP-1 (901)
Government (5230)
Grass and pollen (6)
Guidances (180)
Healthcare (20911)
Huntington's disease (31)
IgA nephropathy (39)
Immunology and inflammation (171)
Immuno-oncology (8)
Indications (37)
Infectious disease (3071)
Inflammatory bowel disease (163)
Inflation Reduction Act (12)
Influenza (64)
Intellectual property (118)
Interviews (813)
IPO (17889)
IRA (54)
Job creations (5192)
Job search strategy (2861)
Kidney cancer (15)
Labor market (53)
Layoffs (582)
Leadership (25)
Legal (10130)
Liver cancer (84)
Lung cancer (414)
Lymphoma (200)
Machine learning (9)
Management (65)
Manufacturing (413)
MASH (92)
Medical device (14693)
Medtech (14698)
Mergers & acquisitions (22535)
Metabolic disorders (886)
Multiple sclerosis (101)
NASH (23)
Neurodegenerative disease (137)
Neuropsychiatric disorders (39)
Neuroscience (2250)
NextGen: Class of 2025 (7687)
Non-profit (5088)
Now hiring (47)
Obesity (467)
Opinion (286)
Ovarian cancer (97)
Pain (115)
Pancreatic cancer (114)
Parkinson's disease (191)
Partnered (25)
Patents (299)
Patient recruitment (143)
Peanut (54)
People (65606)
Pharmaceutical (143)
Pharmacy benefit managers (24)
Phase I (22861)
Phase II (32149)
Phase III (24200)
Pipeline (1607)
Policy (223)
Postmarket research (3552)
Preclinical (10319)
Press Release (72)
Prostate cancer (140)
Psychedelics (39)
Radiopharmaceuticals (277)
Rare diseases (495)
Real estate (7398)
Recruiting (75)
Regulatory (27011)
Reports (61)
Research institute (2663)
Resumes & cover letters (650)
Rett syndrome (9)
RNA editing (9)
RSV (54)
Schizophrenia (92)
Series A (164)
Series B (108)
Service/supplier (30)
Sickle cell disease (64)
Special edition (22)
Spinal muscular atrophy (167)
Sponsored (36)
Startups (4300)
State (2)
Stomach cancer (16)
Supply chain (80)
Tariffs (63)
The Weekly (89)
Vaccines (880)
Venture capital (52)
Weight loss (317)
Women's health (48)
Worklife (20)
Date
Today (142)
Last 7 days (605)
Last 30 days (2785)
Last 365 days (34268)
2025 (16716)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1272)
Alabama (67)
Alaska (7)
Arizona (279)
Arkansas (14)
Asia (50425)
Australia (8865)
California (7486)
Canada (2307)
China (684)
Colorado (320)
Connecticut (338)
Delaware (193)
Europe (115696)
Florida (1106)
Georgia (255)
Hawaii (1)
Idaho (65)
Illinois (713)
India (32)
Indiana (373)
Iowa (18)
Japan (218)
Kansas (115)
Kentucky (31)
Louisiana (17)
Maine (73)
Maryland (1074)
Massachusetts (5727)
Michigan (269)
Minnesota (468)
Mississippi (3)
Missouri (96)
Montana (32)
Nebraska (26)
Nevada (79)
New Hampshire (73)
New Jersey (2087)
New Mexico (31)
New York (2105)
North Carolina (1213)
North Dakota (10)
Northern California (3224)
Ohio (243)
Oklahoma (16)
Oregon (48)
Pennsylvania (1602)
Puerto Rico (18)
Rhode Island (39)
South America (1653)
South Carolina (35)
South Dakota (1)
Southern California (2759)
Tennessee (123)
Texas (1129)
United States (28301)
Utah (222)
Virginia (201)
Washington D.C. (80)
Washington State (660)
West Virginia (4)
Wisconsin (82)
There are 851,177 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
IDeate-Prostate01 Phase 3 Trial of Ifinatamab Deruxtecan Initiated in Patients with Pretreated Metastatic Castration-Resistant Prostate Cancer
June 18, 2025
·
11 min read
Press Releases
Tulavi Therapeutics Appoints Raymond W. Cohen as Vice Chairman of its Board of Directors
June 18, 2025
·
2 min read
Press Releases
Zealand Pharma announces positive topline results from 28-week Phase 1b trial with GLP-1/GLP-2 receptor dual agonist dapiglutide
June 18, 2025
·
8 min read
FDA
Gilead Wins Historic Approval for Twice-Yearly HIV Drug
Lenacapavir, to be marketed as Yeztugo, could “redefine the PReP market,” according to analysts.
June 18, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
JCR Pharmaceuticals Announces Launch of Mucopolysaccharidosis (MPS) Type II Disease Awareness Film Featured in The Next Frontier Series
June 18, 2025
·
4 min read
Press Releases
Saptalis Pharmaceuticals Launches Fluoxetine Oral Solution, USP 20 mg/5 mL
June 18, 2025
·
1 min read
Press Releases
Expanding Innovations Receives FDA Clearance for N-GAGE™ Lumbar Plate System
June 18, 2025
·
2 min read
Press Releases
Yeztugo® (Lenacapavir) Is Now the First and Only FDA-Approved HIV Prevention Option Offering 6 Months of Protection
June 18, 2025
·
15 min read
Press Releases
OnlineSemaglutide.org Launches Platform Offering Easy Access to GLP-1 Medications
June 18, 2025
·
2 min read
Press Releases
Jyong Biotech Ltd. Announces Closing of $20 Million Initial Public Offering
June 18, 2025
·
5 min read
1 of 85,118
Next
